Beta Lactam Adverse Reaction
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Optimization of Perioperative Antibiotic Prophylaxis in Patients Allergic to Beta-lactams in the Orthopedic Surgery and Trauma Departments
B-lactam Databank Algorithm
Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
Beta-lactam Pharmacokinetics in Secondary Care
The Diagnosis of Beta-lactam Hypersensitivity in Thailand
Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.